Effects of the angiotensin-converting enzyme (ACE) inhibitor perindopril on endothelial and platelet functions in essential hypertension

By Okrucka A.   Pechan J.   Lova H. K Ratochvi  

Platelets, Vol. 9, Iss. 1, 1998-01 ,pp. : 63-67

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Effects of Low Dose of Spironolactone and a Thiazide Diuretic in Patients with Hypertension Treated with an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin Type 1 Receptor Blocker

By Yutaka Miyashita   Mifune Mizuo   Kubota Eiji   Itoh Hiroshi   Saito Ikuo  

Clinical and Experimental Hypertension, Vol. 31, Iss. 8, 2009-12 ,pp. : 648-656

Informa Healthcare

Access to resources Recommend Favorite

Effects of Angiotensin-Converting Enzyme Inhibitor on Delayed-Onset Doxorubicin-Induced Cardiotoxicity

By Boucek Robert J.   Steele Ann   Miracle Ann   Atkinson James  

Cardiovascular Toxicology, Vol. 3, Iss. 4, 2003-12 ,pp. : 319-330

Humana Press, Inc

Access to resources Recommend Favorite

Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 3, 2016-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction in relation to left ventricular function

By Reikvam Aasmund   Kvan Elena   Landmark Knud   Aursnes Ivar  

Scandinavian Cardiovascular Journal, Vol. 37, Iss. 3, 2003-01 ,pp. : 130-134

Informa Healthcare

Access to resources Recommend Favorite